Respiratory Infections News

CHICAGO — Women with polycystic ovary syndrome may have an increased mortality risk, particularly death due to cardiovascular disease and diabetes, compared with those without PCOS, according to a study presented at ENDO 2023.

WASHINGTON — In elementary school children with asthma, greater relative humidity in classrooms heightened the risk for upper respiratory infections, according to research presented at the American Thoracic Society International Conference.

The FDA this week approved Pfizer’s respiratory syncytial virus vaccine for adults aged 60 years or older — the second RSV vaccine approved for this population in the last month.

The FDA has approved IV sulbactam-durlobactam to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex.

WASHINGTON — Dyspnea, pain and reduced mobility were frequently reported in survivors of COVID-19 1 year after hospitalization, according to an abstract presented at the American Thoracic Society International Conference.

The National Institute of Allergy and Infectious Diseases announced this week that it has started enrolling participants in a phase 1 trial testing an experimental universal influenza vaccine that uses a messenger RNA platform.

Fewer patients with respiratory failure related to COVID-19 using helmet CPAP experienced intubation compared with facemask CPAP, according to study results published in CHEST.

Adults with bronchiectasis and a Pseudomonas aeruginosa infection had lower bacterial density and better quality of life when treated with tobramycin inhalation solution, according to study results published in CHEST.

Higher CT severity scores at hospitalization and 3 months after were linked to poorer lung function in survivors of COVID-19-associated hyperinflammation, according to study results published in BMC Pulmonary Medicine.

The FDA on Wednesday approved the world’s first vaccine against respiratory syncytial virus, which followed years of failed attempts by scientists to develop one.